The table below shows Beam Therapeutics Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$139.74M
$63.52M
$377.71M
$60.92M
$51.84M
$24.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$409.62M
$367.56M
$437.38M
$311.59M
$387.09M
$103.18M
SG&A
BEAM annual revenue (10-K history)
Beam Therapeutics Inc. reported annual revenue of $139.74M for fiscal year 2025. That is up 120.0% from $63.52M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $18.00K (FY 2019) to $139.74M. Figures come from the company's audited annual reports as filed with the SEC.
